NCT03281590

Brief Summary

This is a single institutional registry database for the patients with stroke and cerebrovascular diseases. Stroke is the fifth leading cause of death in the United States. Despite extensive research, most of the patients die or suffer from varying degree of post-stroke disabilities due to neurologic deficits. This registry aims to understand the disease and examine the disease dynamics in the local community.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,594

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2017

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

September 11, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 13, 2017

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

August 22, 2022

Status Verified

October 1, 2021

Enrollment Period

4.8 years

First QC Date

September 11, 2017

Last Update Submit

August 19, 2022

Conditions

Keywords

identificationdiagnosismanagementinvestigationprevalenceincidencequality of carehospitalizationmorbiditydisability

Outcome Measures

Primary Outcomes (1)

  • Improvement or worsening in stroke signs/symptoms.

    Prospective and retrospective analysis of patients with the acute brain injury, transient ischemic attack, acute and chronic ischemic and hemorrhagic stroke, subarachnoid hemorrhage, and cerebral venous thrombosis from pre-hospitalization, hospitalization (in-patient) and post hospitalization (clinic) data to determine factors which can predict stroke outcome.

    1 year

Study Arms (2)

Patients with stroke

Patients with the Acute Brain injury, Transient Ischemic Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral venous thrombosis from pre-hospitalization, hospitalization (in-patient) and post hospitalization (clinic) data

Patients without stroke

Control subject who have the risk factors but never had stroke.

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a final/discharge diagnosis of stroke or transient ischemic attack can be included into the Stroke Registry. This includes cases with a principal/primary or secondary diagnosis of: * Cerebral Infarction * Intracerebral Hemorrhage (non-traumatic) * Ischemic Stroke * Subarachnoid Hemorrhage (non-traumatic) * Transient Ischemic Attack (TIA) * Acute Brain Injury * Cerebral Venous Sinus Thrombosis The investigators will use the available EMR and databases to search for these patients using relevant ICD-9/10 codes.

You may qualify if:

  • All patients with a diagnosis of Acute Brain injury, Transient Ischemic Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral venous thrombosis seen in UNMH.
  • Age \>1 years of age.

You may not qualify if:

  • Patients who don't have the diagnosis of Acute Brain injury, Transient Ischemic Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral venous thrombosis.
  • Patients who have Epidural Hematoma, Subdural hematoma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, University of New Mexico

Albuquerque, New Mexico, 87131-0007, United States

Location

MeSH Terms

Conditions

StrokeBrain InjuriesIschemic StrokeHemorrhagic StrokeIschemic Attack, TransientSubarachnoid HemorrhageBrain IschemiaCerebral InfarctionSinus Thrombosis, IntracranialDisease

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesIntracranial HemorrhagesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsBrain InfarctionInfarctionIschemiaNecrosisIntracranial ThrombosisIntracranial Embolism and ThrombosisThromboembolismEmbolism and Thrombosis

Study Officials

  • Michel Torbey, MD, MPH

    University of New Mexico

    STUDY CHAIR
  • Atif Zafar, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR
  • Asad Ikram, MD

    University of New Mexico

    STUDY DIRECTOR
  • Mudassir Farooqui, MD, MPH

    University of New Mexico

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2017

First Posted

September 13, 2017

Study Start

September 6, 2017

Primary Completion

June 10, 2022

Study Completion

June 10, 2022

Last Updated

August 22, 2022

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations